Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Staley A Brod

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Multiple Sclerosis and Related Disorders|May 16, 2021
Immune reconstitution therapy in NMOSDStaley A Brod
Cytokine|November 15, 2012
Ingested (oral) thyrotropin releasing factor (TRH) inhibits EAEStaley A Brod, Victoria Bauer
Journal of Neuroimmunology|January 2, 2007
Ingested (oral) SIRS peptide 1-21 inhibits acute EAE by inducing Th2-like cytokinesStaley A Brod, Zachary Hood
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 29, 2008
Ingested (oral) SIRS peptide 1-21 suppresses type 1 diabetes in NOD miceStaley A Brod, Zachary Hood
Autoimmunity|January 20, 2011
Ingested (oral) SST inhibits EAEStaley A Brod, Zachary M Hood
Cytokine|May 22, 2014
Ingested (oral) tocilizumab inhibits EAEStaley A Brod, Victoria L Bauer
Journal of Neuroimmunology|June 19, 2012
Ingested (oral) neuropeptide Y inhibits EAEStaley A Brod, Victoria L Bauer
Journal of Neuroimmunology|November 27, 2007
Ingested (oral) alpha-MSH inhibits acute EAEStaley A Brod, Zachary M Hood
Journal of Neuroimmunology|November 18, 2010
Ingested (oral) ACTH inhibits EAEStaley A Brod, Zachary M Hood
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 17, 2012
Oral ACTH (H.P. Acthar(®)Gel) inhibits IL-1 and IL-17 secretion in humansStaley A Brod, Victoria Bauer, Zachary Hood
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Multiple Sclerosis and Related Disorders|May 16, 2021
Immune reconstitution therapy in NMOSDStaley A Brod
Cytokine|November 15, 2012
Ingested (oral) thyrotropin releasing factor (TRH) inhibits EAEStaley A Brod, Victoria Bauer
Journal of Neuroimmunology|January 2, 2007
Ingested (oral) SIRS peptide 1-21 inhibits acute EAE by inducing Th2-like cytokinesStaley A Brod, Zachary Hood
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 29, 2008
Ingested (oral) SIRS peptide 1-21 suppresses type 1 diabetes in NOD miceStaley A Brod, Zachary Hood
Autoimmunity|January 20, 2011
Ingested (oral) SST inhibits EAEStaley A Brod, Zachary M Hood
Cytokine|May 22, 2014
Ingested (oral) tocilizumab inhibits EAEStaley A Brod, Victoria L Bauer
Journal of Neuroimmunology|June 19, 2012
Ingested (oral) neuropeptide Y inhibits EAEStaley A Brod, Victoria L Bauer
Journal of Neuroimmunology|November 27, 2007
Ingested (oral) alpha-MSH inhibits acute EAEStaley A Brod, Zachary M Hood
Journal of Neuroimmunology|November 18, 2010
Ingested (oral) ACTH inhibits EAEStaley A Brod, Zachary M Hood
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 17, 2012
Oral ACTH (H.P. Acthar(®)Gel) inhibits IL-1 and IL-17 secretion in humansStaley A Brod, Victoria Bauer, Zachary Hood
Pageof 3